CClinicalTrials.gg
CompletedNCT01603966Updated Jul 17, 2012

Low Dose Aspirin Studied With the AggreGuide

An observational study in Platelet Aggregation, sponsored by Edward R. Teitel, M.D.. Completed at 1 site in United States. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2012-07-17.

Sponsored by Edward R. Teitel, M.D. · Observational

Study type
Observational
Model
Case-crossover
Time perspective
Prospective
Enrollment
13
Ages
18 Years to 70 Years
Sex
All
01

Study summary

This study is to determine whether the AggreGuide platelet aggregometer can discern the effect of low dose aspirin on subjects platelet aggregation using arachidonic acid as the agonist.

02

Conditions studied

  • Platelet Aggregation

Keywords

  • platelet
  • aggregation
  • aspirin
  • inhibition
  • reactivity
03

In context

Lead sponsor

This is the only study on the registry with Edward R. Teitel, M.D. as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

community sample

Inclusion criteria

  • adults

Exclusion criteria

Exclusion Criteria:

  • aspirin contraindications
  • anticoagulants
  • aspirin past week
05

Study design

Observational model
Case-crossover
Time perspective
Prospective
Enrollment
13 participants (actual)
Biospecimen retention
None retained
06

Study locations

1 site
  • Aggredyne, Inc.
    Houston, Texas 77099, United States
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 17, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT01603966
Lead sponsor
Edward R. Teitel, M.D.
Responsible party
Edward R. Teitel, M.D. (CEO, Aggredyne, Inc.) — Sponsor-investigator
First posted
May 23, 2012
Start date
Apr 2012
Primary completion
Jun 2012
Completion
Jun 2012
Last update
Jul 17, 2012

Study contacts

Edward R. Teitel, MD
principal investigator · Aggredyne, Inc.

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion